Compare
Groupon, Inc. vs Stran & Company, Inc. vs Stagwell Inc vs Haoxi Health Technology Ltd
| Latest fiscal year | Groupon, Inc. GRPN | Stran & Company, Inc. SWAG | Stagwell Inc STGW | Haoxi Health Technology Ltd HAO |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2026-06-30 |
| Revenue | $498.42M | $116.19M | $2.91B | $54.83M |
| Revenue growth (YoY) | +1.2% | +40.6% | +2.4% | +67.1% |
| Gross margin | 90.8% | 29.5% | 36.5% (computed) | 1.1% |
| Operating margin | 4.7% | -1.7% | 5.5% | -17.6% |
| Net margin | -16.8% | -0.6% | 1.0% | -17.4% |
| Net income | -$83.52M | -$747.0K | $29.10M | -$9.54M |
| EPS (Diluted) | -$2.08 | -$0.04 | n/a | -$386.40 |
| Operating cash flow | $64.50M | -$4.67M | $291.03M | -$2.57M |
| Free cash flow | $49.87M | -$5.50M | $247.29M | n/a |
| Cash & equivalents | $296.08M | $6.75M | $104.54M | $10.93M |
| Total assets | $670.41M | $49.35M | $4.21B | $21.57M |
| Total liabilities | $712.80M | $18.85M | $3.41B | $3.71M |
| Shareholders' equity | -$42.39M | $30.50M | $758.39M | $17.86M |
| Return on year-end equity | n/a | -2.4% | 3.8% | -53.4% |
| Shares outstanding | 40.73M | 18.51M | n/a | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Groupon, Inc. | Stran & Company, Inc. | Stagwell Inc | Haoxi Health Technology Ltd |
|---|---|---|---|---|
| Latest | $498.42M Ended 2025-12-31 | $116.19M Ended 2025-12-31 | $2.91B Ended 2025-12-31 | $54.83M Ended 2026-06-30 |
| 1 year earlier | $492.56M Ended 2024-12-31 | $82.65M Ended 2024-12-31 | $2.84B Ended 2024-12-31 | $32.80M Ended 2025-06-30 |
| 2 years earlier | $514.91M Ended 2023-12-31 | $76.00M Ended 2023-12-31 | $2.53B Ended 2023-12-31 | $48.52M Ended 2024-06-30 |
| 3 years earlier | $599.09M Ended 2022-12-31 | $57.88M Ended 2022-12-31 | $2.69B Ended 2022-12-31 | $28.23M Ended 2023-06-30 |
| 4 years earlier | $967.11M Ended 2021-12-31 | $39.70M Ended 2021-12-31 | $1.47B Ended 2021-12-31 | $16.16M Ended 2022-06-30 |